Search

Your search keyword '"Bochtler T"' showing total 11 results
Start Over Author "Bochtler T" Publisher elsevier b.v.
11 results on '"Bochtler T"'

1. Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Author

Christopoulos, P., Kirchner, M., Roeper, J., Saalfeld, F., Janning, M., Bozorgmehr, F., Magios, N., Kazdal, D., Volckmar, A.L., Brückner, L.M., Bochtler, T., Kriegsmann, M., Endris, V., Penzel, R., Kriegsmann, K., Eichhorn, M., Herth, F.J.F., Heussel, C.P., El Shafie, R.A., Schneider, M.A., Muley, T., Meister, M., Faehling, M., Fischer, J.R., Heukamp, L., Schirmacher, P., Bischoff, H., Wermke, M., Loges, S., Griesinger, F., Stenzinger, A., and Thomas, M.

Published
2020
Full Text
View/download PDF

2. 200P Outcomes of patients (pts) with unfavourable, non-squamous cancer of unknown primary (CUP) progressing after induction chemotherapy (CTX) in the global, open-label, phase II CUPISCO study.

Author

Bochtler, T., Krämer, A., Pauli, C., Durán-Pacheco, G., Arslan, C., Bigot, F., Chalabi, N., Cook, N., Italiano, A., Losa, F., Menezes, J., Ma, N., Ozguroglu, M., Cid, R.A. Pazo, Ross, J.S., Shiu, K-K., Arni, P., Moch, H., and Mileshkin, L.

Subjects
*CANCER of unknown primary origin, *INDUCTION chemotherapy
Published
2024
Full Text
View/download PDF

3. Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Author

Krämer, A., Bochtler, T., Pauli, C., Baciarello, G., Delorme, S., Hemminki, K., Mileshkin, L., Moch, H., Oien, K., Olivier, T., Patrikidou, A., Wasan, H., Zarkavelis, G., Pentheroudakis, G., and Fizazi, K.

Subjects
*CANCER of unknown primary origin, *DIAGNOSIS
Abstract

• This ESMO Clinical Practice Guideline provides key recommendations for managing cancer of unknown primary (CUP). • The guideline covers CUP diagnosis, risk assessment, classification, treatment and follow-up. • Differential diagnostic algorithms for discrimination between CUP and other cancers are provided. • The author group includes multidisciplinary experts from different institutions in Europe, Australia and the United States. • Recommendations are based on available scientific data and the authors' collective expert opinion. • In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

4. LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP)

Author

Mileshkin, L., Bochtler, T., Pauli, C., Durán-Pacheco, G., Arslan, C., Bigot, F., Chalabi, N., Cook, N., Italiano, A., Losa, F., Menezes, J., Michaud, C., Ozguroglu, M., Pazo Cid, R.A., Ross, J.S., Shiu, K-K., Stahl, M., Thomas, M., Moch, H., and Krämer, A.

Subjects
*CANCER treatment, *IMMUNOTHERAPY, *CANCER chemotherapy, *DIAGNOSIS, *SAFETY, *OVARIAN cancer
Published
2023
Full Text
View/download PDF

10. 738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trial.

Author

Pouyiourou, M., Kraft, B., Wohlfromm, T., Stahl, M., Kubuschok, B., Löffler, H., Hacker, U.T., Huebner, G., Westphalen, C.B., Bitzer, M., Ernst, T., Schuett, P., Hielscher, T., Delorme, S., Stenzinger, A., Bochtler, T., and Krämer, A.

Subjects
*CANCER of unknown primary origin, *CANCER patients, *NIVOLUMAB, *IPILIMUMAB
Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results